1,25(OH)2D3 regulates collagen quality in an osteoblastic cell culture system

Biochemical and Biophysical Research Communications

Volumn 377, Issue 2, 2008, Pages 674-678

  Nagaoka, Hideaki ^a,b   Mochida, Yoshiyuki ^a   Atsawasuwan, Phimon ^a   Kaku, Masaru ^a   Kondoh, Toshirou ^b   Yamauchi, Mitsuo ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Collagen cross link; Collagen post translational modification; MC3T3 E1; Vitamin D

Indexed keywords

ALDEHYDE DERIVATIVE; CALCITRIOL; COLECALCIFEROL; COLLAGEN; HYDROXYLYSINE; LYSYL HYDROXYLASE 1; LYSYL HYDROXYLASE 2; LYSYL HYDROXYLASE 3; LYSYL OXIDASE 1; LYSYL OXIDASE 2; LYSYL OXIDASE 3; LYSYL OXIDASE 4; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE; PROTEIN LYSINE 6 OXIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; GENE EXPRESSION REGULATION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; QUALITY CONTROL; REGULATORY MECHANISM; UPREGULATION;

ALTERNATIVE SPLICING; ANIMALS; BIOLOGICAL MARKERS; CALCITRIOL; CELL LINE; CHOLECALCIFEROL; COLLAGEN; ETHANOL; GENE EXPRESSION; ISOENZYMES; LYSINE; MICE; OSTEOBLASTS; OSTEOGENESIS; PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-LYSINE 6-OXIDASE;

EID: 55649115736     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.036     Document Type: Article

References (39)

1. Norman A.W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am. J. Clin. Nutr. 88 (2008) 491S-499S
2. Feldman D., Pike J.W., and Glorieux F. Vitamin D (2005), Elsevier Academic Press, Burlington
3. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80 (2004) 1689S-1696S
4. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., Lieben L., Mathieu C., and Demay M. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. (2008)
5. Suda T., Ueno Y., Fujii K., and Shinki T. Vitamin D and bone. J. Cell. Biochem. 88 (2003) 259-266
6. Ebert R., Schutze N., Adamski J., and Jakob F. Vitamin D signaling is modulated on multiple levels in health and disease. Mol. Cell. Endocrinol. 248 (2006) 149-159
7. St-Arnaud R. The direct role of vitamin D on bone homeostasis. Arch. Biochem. Biophys. 473 (2008) 225-230
8. Yamauchi M. Collagen Biochemistry: an Overview (2002), World Scientific Publishing, Singapore
9. Pornprasertsuk S., Duarte W.R., Mochida Y., and Yamauchi M. Lysyl hydroxylase-2b directs collagen cross-linking pathways in MC3T3-E1 cells. J. Bone Miner Res. 19 (2004) 1349-1355
10. Pornprasertsuk S., Duarte W.R., Mochida Y., and Yamauchi M. Overexpression of lysyl hydroxylase-2b leads to defective collagen fibrillogenesis and matrix mineralization. J. Bone Miner Res. 20 (2005) 81-87
11. Bank R.A., Robins S.P., Wijmenga C., Breslau-Siderius L.J., Bardoel A.F., van der Sluijs H.A., Pruijs H.E., and TeKoppele J.M. Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc. Natl. Acad. Sci. USA 96 (1999) 1054-1058
12. Matsumoto T., Igarashi C., Takeuchi Y., Harada S., Kikuchi T., Yamato H., and Ogata E. Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells. Bone 12 (1991) 27-32
13. Harrison J.R., Petersen D.N., Lichtler A.C., Mador A.T., Rowe D.W., and Kream B.E. 1,25-Dihydroxyvitamin D3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17/2.8. Endocrinology 125 (1989) 327-333
14. Franceschi R.T., Romano P.R., and Park K.Y. Regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D3 in human osteosarcoma cells. J. Biol. Chem. 263 (1988) 18938-18945
15. Hicok K.C., Thomas T., Gori F., Rickard D.J., Spelsberg T.C., and Riggs B.L. Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J. Bone Miner Res. 13 (1998) 205-217
16. Lichtler A., Stover M.L., Angilly J., Kream B., and Rowe D.W. Isolation and characterization of the rat alpha 1(I) collagen promoter. Regulation by 1,25-dihydroxyvitamin D. J. Biol. Chem. 264 (1989) 3072-3077
17. Bedalov A., Salvatori R., Dodig M., Kapural B., Pavlin D., Kream B.E., Clark S.H., Woody C.O., Rowe D.W., and Lichtler A.C. 1,25-Dihydroxyvitamin D3 inhibition of col1a1 promoter expression in calvariae from neonatal transgenic mice. Biochim. Biophys. Acta 1398 (1998) 285-293
18. Parisuthiman D., Mochida Y., Duarte W.R., and Yamauchi M. Biglycan modulates osteoblast differentiation and matrix mineralization. J. Bone Miner Res. 20 (2005) 1878-1886
19. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
20. Yeowell H.N., and Walker L.C. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI. Mol. Genet. Metab. 71 (2000) 212-224
21. Yamauchi M., and Shiiba M. Lysine hydroxylation and cross-linking of collagen. Methods Mol. Biol. 446 (2008) 95-108
22. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., Kawakami T., Arioka K., Sato H., Uchiyama Y., Masushige S., Fukamizu A., Matsumoto T., and Kato S. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 16 (1997) 391-396
23. Shiraishi A., Higashi S., Masaki T., Saito M., Ito M., Ikeda S., and Nakamura T. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis. Calcif. Tissue Int. 71 (2002) 69-79
24. Gallagher J.C., Fowler S.E., Detter J.R., and Sherman S.S. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J. Clin. Endocrinol. Metab. 86 (2001) 3618-3628
25. Papadimitropoulos E., Wells G., Shea B., Gillespie W., Weaver B., Zytaruk N., Cranney A., Adachi J., Tugwell P., Josse R., Greenwood C., and Guyatt G. Meta-analyses of therapies for postmenopausal osteoporosis. VIII. Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr. Rev. 23 (2002) 560-569
26. Gallagher J.C., Riggs B.L., Recker R.R., and Goldgar D. The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc. Soc. Exp. Biol. Med. 191 (1989) 287-292
27. Tilyard M.W., Spears G.F., Thomson J., and Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N. Engl. J. Med. 326 (1992) 357-362
28. Li Y.C., Bergwitz C., Juppner H., and Demay M.B. Cloning and characterization of the vitamin D receptor from Xenopus laevis. Endocrinology 138 (1997) 2347-2353
29. Amling M., Priemel M., Holzmann T., Chapin K., Rueger J.M., Baron R., and Demay M.B. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140 (1999) 4982-4987
30. Stumpf W.E., Koike N., Hayakawa N., Tokuda K., Nishimiya K., Tsuchiya Y., Hirate J., Okazaki A., and Kumaki K. 1,25-Dihydroxyvitamin D3 and 22-oxa-1,25-dihydroxyvitamin D3 in vivo nuclear receptor binding in developing bone during endochondral and intramembranous ossification. Histochemistry 102 (1994) 183-194
31. Owen T.A., Aronow M.S., Barone L.M., Bettencourt B., Stein G.S., and Lian J.B. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128 (1991) 1496-1504
32. Eelen G., Verlinden L., van Camp M., van Hummelen P., Marchal K., de Moor B., Mathieu C., Carmeliet G., Bouillon R., and Verstuyf A. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes. J. Bone Miner Res. 19 (2004) 133-146
33. Drissi H., Pouliot A., Koolloos C., Stein J.L., Lian J.B., Stein G.S., and van Wijnen A.J. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Exp. Cell Res. 274 (2002) 323-333
34. Eyre D., Shao P., Weis M.A., and Steinmann B. The kyphoscoliotic type of Ehlers-Danlos syndrome (type VI): differential effects on the hydroxylation of lysine in collagens I and II revealed by analysis of cross-linked telopeptides from urine. Mol. Genet. Metab. 76 (2002) 211-216
35. Uzawa K., Grzesik W.J., Nishiura T., Kuznetsov S.A., Robey P.G., Brenner D.A., and Yamauchi M. Differential expression of human lysyl hydroxylase genes, lysine hydroxylation, and cross-linking of type I collagen during osteoblastic differentiation in vitro. J. Bone Miner Res. 14 (1999) 1272-1280
36. Atsawasuwan P., Mochida Y., Parisuthiman D., and Yamauchi M. Expression of lysyl oxidase isoforms in MC3T3-E1 osteoblastic cells. Biochem. Biophys. Res. Commun. 327 (2005) 1042-1046
37. Riggs B.L., Wahner H.W., Seeman E., Offord K.P., Dunn W.L., Mazess R.B., Johnson K.A., and Melton III L.J. Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J. Clin. Invest. 70 (1982) 716-723
38. Dempster D.W. The contribution of trabecular architecture to cancellous bone quality. J. Bone Miner Res. 15 (2000) 20-23
39. Goldstein S.A., Goulet R., and McCubbrey D. Measurement and significance of three-dimensional architecture to the mechanical integrity of trabecular bone. Calcif. Tissue Int. 53 Suppl. 1 (1993) S127-S132 (discussion S132-S123)